UNITED THERAPEUTICS (UTHR) EBIAT: 2009-2025
Historic EBIAT for UNITED THERAPEUTICS (UTHR) over the last 17 years, with Sep 2025 value amounting to $338.7 million.
- UNITED THERAPEUTICS's EBIAT rose 9.58% to $338.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year increase of 14.47%. This contributed to the annual value of $1.2 billion for FY2024, which is 21.35% up from last year.
- UNITED THERAPEUTICS's EBIAT amounted to $338.7 million in Q3 2025, which was up 9.43% from $309.5 million recorded in Q2 2025.
- Over the past 5 years, UNITED THERAPEUTICS's EBIAT peaked at $338.7 million during Q3 2025, and registered a low of $28.3 million during Q1 2021.
- Its 3-year average for EBIAT is $286.4 million, with a median of $301.3 million in 2024.
- Per our database at Business Quant, UNITED THERAPEUTICS's EBIAT plummeted by 79.45% in 2021 and then skyrocketed by 747.70% in 2022.
- Over the past 5 years, UNITED THERAPEUTICS's EBIAT (Quarterly) stood at $112.2 million in 2021, then climbed by 17.74% to $132.1 million in 2022, then spiked by 64.35% to $217.1 million in 2023, then skyrocketed by 38.78% to $301.3 million in 2024, then grew by 9.58% to $338.7 million in 2025.
- Its last three reported values are $338.7 million in Q3 2025, $309.5 million for Q2 2025, and $322.2 million during Q1 2025.